USA flag logo/image

An Official Website of the United States Government

Novel Materials and Methods for Separations of Glycopeptides and Glycans

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
Program Year/Program:
2013 / SBIR
Agency Tracking Number:
R44GM093747
Solicitation Year:
2013
Solicitation Topic Code:
NIGMS
Solicitation Number:
PA11-215
Small Business Information
ADVANCED MATERIALS TECHNOLOGY, INC.
3521 SILVERSIDE ROAD, SUITE 1-K, QUILLEN BLDG WILMINGTON, DE 19810-
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 2013
Title: Novel Materials and Methods for Separations of Glycopeptides and Glycans
Agency: HHS
Contract: 2R44GM093747-02
Award Amount: $1,161,877.00
 

Abstract:

DESCRIPTION (provided by applicant): Analysis of glycoprotein polypeptide sites of carbohydrate attachment and the structures of the glycans present on these proteins requires the combination of high resolution chromatographic separations and sophisticatedmass spectrometry. Hydrophilic interaction liquid chromatography (HILIC) has great use in separations of glycopeptides and released glycans, exhibiting remarkable selectivity for the separations of glycoforms. The proposed effort is to markedly improve separations of glycopeptides and released glycans by HILIC, reducing the separation times from the current 2-3 hours per sample, to 30 minutes or less. The separations component of LC/MS analysis of glycoproteins can benefit from the design of more efficientstationary phase chromatographic materials, and from the use of conditions that allow direct and productive interfacing with mass spectrometers. We propose that recently developed superficially-porous silica microparticulate silica packing materials (Fused-Core(R) structures) can achieve these separation speeds, without loss of the required high resolution. The AMT Fused-Core reversed phase materials have previously been shown to exhibit superior kinetic properties and column efficiencies for separations of small molecules, and recently, wider pore size packings have shown a similar benefit for larger peptides (c. 3-5 kDa). The current proposal uses Fused-Core technology with unique surface modifications to develop high performance HILIC materials specifically for separations of glycopeptides and glycans. Tailored HILIC materials will be synthesized and tested for HILIC operation, as well as to establish the fundamental relationships between surface properties, particle characteristics, and utility for glycan and glycopeptides separations. The new bonded phases utilize organosilane chemistry discovered in Phase I efforts that have been selected to withstand aggressive conditions of use, permitting stable and robust separations materials that can be used across a broad range of conditions. Preliminary LC/MS applications in glycoproteomic applications have been completed in Phase. A reasonable estimate is that an improvement of gt2-fold for separations times are obtained. Phase II will expand on this effort, with the purpose of delivering further improved materials and methods to a broader range of needs in glycoproteomics and proteomics workflows. A significant aspect of the current proposal will assess the benefits and real-world applications of these new separations materials. The target of this work is to produce robust materials that permit simple integration with online mass spectrometry analysis, effective for resolution of the complex mixtures that are typical of current glycoprotein identification and structural characterization procedures. PUBLIC HEALTH RELEVANCE PUBLIC HEALTH RELEVANCE: Protein modification by the addition of sugars (called glycosylation) is extremely common in nature, and this modification exhibits a strong effect on protein structure and on biological function. In certain diseases, most notably in cancer and for some infectious diseases like influenza, glycosylation of proteins, or recognition of such proteins, is altered in ways that are not fully understood. In some casesthese alterations are big enough to allow them to be used for recognition of disease, and in some cases to stratify patients. The current proposal is to use new knowledge in materials science and chemistry to enable much faster and more efficient ways todiscover glycosylation disease markers and to better understand the biology of glycosylation.

Principal Investigator:

Barry E. Boyes
302-981-0853
bboyes@advanced-materials-tech.com

Business Contact:

Joseph Destefano
302-477-2510
joedestefano@advanced-materials-tec
Small Business Information at Submission:

ADVANCED MATERIALS TECHNOLOGY, INC.
3521 SILVERSIDE ROAD, SUITE 1-K, QUILLEN BLDG WILMINGTON, DE 19810-

EIN/Tax ID: 120235749
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No